TNFSF10 and neoplasm: To evaluate the immunomodulatory effects of exogenous recombinant TRAIL in the tumor immune microenvironment, we established two tumor models, 4T1 and CT26, in BALB/c mice and treated them with three concentrations of smTRAIL.